Major Investor Fairmount Converts Preferred Stock, Agrees to 60-Day Lock-Up
GLTO has more than doubled off its 52-week low of $2.01 on elevated volume (4.7× avg).
Summary
Fairmount Funds Management LLC converted a substantial amount of Series C Preferred Stock into common stock, now holding 19.99% of Galecto, Inc., and agreed to a 60-day lock-up in connection with the company's recent public offering.
Key Events · Ownership and Investor Activity · GLTO
-
Preferred Stock Conversion
Fairmount Funds Management LLC and its affiliates converted 8,713 shares of Series C Preferred Stock into 8,713,000 shares of common stock on February 9, 2026, following stockholder approval.
-
Significant Ownership Stake
Following the conversion, Fairmount Funds Management LLC now beneficially owns 8,713,000 shares of common stock, representing 19.99% of the company's outstanding shares.
-
60-Day Lock-Up Agreement
In connection with Galecto's recent public offering, Fairmount Funds Management LLC, Fund II, Co-Invest, and Peter Harwin entered into a lock-up agreement preventing the sale or transfer of their securities for 60 days from February 10, 2026.
-
Potential Future Dilution
The filing notes that an additional 18,088,000 shares of common stock issuable upon conversion of Series B and Series C Preferred Stock are currently excluded due to a 19.99% beneficial ownership limitation, indicating a substantial potential for future dilution.
Analysis · GLTO · Life Sciences
This Schedule 13D/A provides critical updates regarding a major investor, Fairmount Funds Management LLC, in the context of Galecto's recent flurry of financing activities. The conversion of a significant block of Series C Preferred Stock into 8.7 million common shares, representing 19.99% ownership, formalizes a substantial portion of the company's capital structure. While this conversion itself is a mechanical event, it makes these shares part of the common stock float. Crucially, Fairmount has agreed to a 60-day lock-up, preventing immediate sales of these shares following the company's recent public offering. This temporary restriction on a large shareholder's ability to sell provides some short-term stability amidst recent dilutive capital raises. However, the disclosure also highlights a substantial overhang of approximately 18 million additional shares of preferred stock that could convert to common stock once the 19.99% beneficial ownership limitation is no longer a factor, signaling significant potential for future dilution. Investors should monitor Fairmount's future actions and any changes to the beneficial ownership limitations.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 36.7% of the 1072 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.61%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GLTO was trading at $20.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $34.8M. The 52-week trading range was $2.01 to $38.33. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.